Leuthold Group, LLC Charles River Laboratories International, Inc. Transaction History

Leuthold Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$255.51 - $362.11 $351,070 - $497,539	-1,374 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$351.38 - $448.68 $5,622 - $7,178	-16 Reduced 1.15%	1,374 $518,000
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $11,178 - $14,122	-38 Reduced 2.66%	1,390 $514,000
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $8,738 - $10,481	-35 Reduced 2.39%	1,428 $414,000
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $13,098 - $14,904	-59 Reduced 3.88%	1,463 $366,000
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $7,549 - $9,737	-43 Reduced 2.75%	1,522 $345,000
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $2,614 - $4,173	-22 Reduced 1.39%	1,565 $273,000
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $156,954 - $283,025	1,587 New	1,587 $200,000
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $5.31 Million - $6.24 Million	-54,129 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $5.44 Million - $6.39 Million	54,129	54,129 $5.92 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.